{"schema_version":"secwatch.filing_event.v1","accession":"0000721371-25-000003","form_type":"8-K","ticker":"CAH","cik":"0000721371","company_name":"CARDINAL HEALTH INC","filed_at":"2025-01-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.181994+00:00","generated_at":"2026-05-28T02:28:28.947585+00:00","sec_items":["7.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Cardinal Health raises FY2025 non-GAAP EPS guidance to high end of $7.75-$7.90 range","bullets":["Now expects FY2025 non-GAAP EPS toward high end of $7.75 to $7.90, driven by Pharmaceutical & Specialty Solutions strength.","Previous guidance range was $7.75-$7.90; update reflects improved segment performance.","Presenting at JP Morgan 43rd Annual Healthcare Conference on January 14, 2025.","Further details on FY2025 expectations to be provided on Q2 earnings call January 30, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000721371-25-000003","json":"https://secwatch.observer/filing/0000721371-25-000003.json","markdown":"https://secwatch.observer/filing/0000721371-25-000003.md","text":"https://secwatch.observer/filing/0000721371-25-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/721371/000072137125000003/0000721371-25-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/721371/000072137125000003/cah-20250114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T02:28:28.947585+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}